KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Long-Term Investments (2016 - 2025)

Evolent Health (EVH) has 10 years of Long-Term Investments data on record, last reported at $8.9 million in Q3 2025.

  • For Q3 2025, Long-Term Investments rose 6.32% year-over-year to $8.9 million; the TTM value through Sep 2025 reached $8.9 million, up 6.32%, while the annual FY2024 figure was $15.0 million, 11.06% down from the prior year.
  • Long-Term Investments reached $8.9 million in Q3 2025 per EVH's latest filing, roughly flat from $9.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $16.9 million in Q4 2023 and bottomed at $4.1 million in Q1 2023.
  • Average Long-Term Investments over 5 years is $9.7 million, with a median of $8.9 million recorded in 2025.
  • Peak YoY movement for Long-Term Investments: crashed 93.46% in 2021, then soared 291.3% in 2024.
  • A 5-year view of Long-Term Investments shows it stood at $5.5 million in 2021, then skyrocketed by 128.4% to $12.5 million in 2022, then soared by 35.28% to $16.9 million in 2023, then fell by 11.06% to $15.0 million in 2024, then crashed by 40.42% to $8.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $8.9 million in Q3 2025, $9.0 million in Q2 2025, and $8.6 million in Q1 2025.